{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:16:03Z","timestamp":1773288963002,"version":"3.50.1"},"reference-count":46,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T00:00:00Z","timestamp":1239062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p> <jats:italic>Background<\/jats:italic>: Increased anandamide, an endocannabinoid that interacts with both cannabinoid CB<jats:sub>1<\/jats:sub> and CB<jats:sub>2<\/jats:sub> receptors, can induce hepatic vasoconstrictive responses that contribute to the increased intrahepatic resistance (IHR) in cirrhotic rats. Chronic endotoxaemia and the subsequent release of tumour necrosis factor\u2010\u03b1 (TNF\u2010\u03b1) are suggested to result in increased anandamide in cirrhotic livers. Thalidomide, which inhibited TNF\u2010\u03b1 effectively, has been used clinically in states of chronic TNF\u2010\u03b1 elevation with encouraging results. <jats:italic>Aims<\/jats:italic>: This study explores the possible effects of thalidomide on hepatic endocannabinoids and microcirculation of cirrhotic rats. <jats:italic>Methods<\/jats:italic>: Portal venous pressure (PVP), superior mesenteric arterial blood flow (SMA BF), hepatic TNF\u2010\u03b1, interleukin (IL\u20106), protein expression of CB<jats:sub>1<\/jats:sub> and CB<jats:sub>2<\/jats:sub> receptor and thromboxane synthase (TXS) were measured in bile duct\u2010ligated (BDL) rats receiving 1\u2010month of vehicle (BDL\u2010V) or thalidomide (BDL\u2010thalido). The degree of hepatic fibrosis was also assessed. In the liver perfusion system, IHR and concentration\u2013response curves of the portal perfusion pressure to anandamide were evaluated. <jats:italic>Results<\/jats:italic>: In BDL\u2010thalido rats, PVP, IHR and hepatic levels of TNF\u2010\u03b1 and IL\u20106, protein expression of CB<jats:sub>1<\/jats:sub> receptors, TXS and hepatic fibrosis were lower than in BDL\u2010V rats. In BDL\u2010thalido rat livers, the attenuation of the vasoconstrictive response to anandamide was associated with an upregulation of the CB<jats:sub>2<\/jats:sub> receptor and a downregulation of the CB<jats:sub>1<\/jats:sub> receptor. Nevertheless, SMA BF was not different between BDL\u2010thalido and BDL\u2010V rats. <jats:italic>Conclusions<\/jats:italic>: Thalidomide decreased the PVP and IHR through the attenuation of anandamide\u2010induced constrictive response, decreasing the production of TNF\u2010\u03b1, IL\u20106 and TXA<jats:sub>2<\/jats:sub> in the liver and the suppression of hepatic fibrogenesis of rats with biliary cirrhosis of this study.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2009.01983.x","type":"journal-article","created":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T14:23:36Z","timestamp":1239114216000},"page":"678-685","source":"Crossref","is-referenced-by-count":14,"title":["Inhibition of hepatic tumour necrosis factor\u2010\u03b1 attenuates the anandamide\u2010induced vasoconstrictive response in cirrhotic rat livers"],"prefix":"10.1111","volume":"29","author":[{"given":"Ying\u2010Ying","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuei\u2010Chuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2010Tsau","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa\u2010Yauh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u2010Yang","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che\u2010Chuan","family":"Loong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han\u2010Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou\u2010Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/89953"},{"key":"e_1_2_6_3_2","first-page":"543","article-title":"CB1 cannabinoid receptor antagonism","volume":"45","author":"Wasmuth HE","year":"2007","journal-title":"a new strategy for the treatment of liver fibrosis"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.12.11.1035"},{"key":"e_1_2_6_5_2","first-page":"E298","article-title":"Cannbinoid receptors and endocannabinoids","volume":"8","author":"Mackie K","year":"2006","journal-title":"evidence for new player"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50341"},{"key":"e_1_2_6_7_2","first-page":"718","article-title":"Sepsis in cirrhosis","volume":"54","author":"Wong F","year":"2005","journal-title":"report on the 7th meeting of the international ascites club"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(02)00058-2"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80272-X"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.03.019"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)06020-6"},{"key":"e_1_2_6_12_2","first-page":"23","article-title":"Cytokines levels in acute alcoholic hepatitis","volume":"39","author":"Rodriguez RE","year":"1995","journal-title":"a sequential study"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230203"},{"key":"e_1_2_6_14_2","first-page":"G387","article-title":"Mechanisms of hepatic toxicity I. TNF\u2010induced liver injury","volume":"275","author":"Bradham CA","year":"1998","journal-title":"Am J Physiol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260621"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100938200"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.34161"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.6.1675"},{"key":"e_1_2_6_19_2","first-page":"1271","article-title":"Thalidomide therapy for patients with refractory Crohn's disease","volume":"117","author":"Ehrenpreis ED","year":"1999","journal-title":"an open-label trial"},{"key":"e_1_2_6_20_2","first-page":"1501","article-title":"Effects of thalidomide on HIV\u2010associated wasting syndrome","volume":"10","author":"Reyes\u2010Teran G","year":"1996","journal-title":"a randomized, double-blind, placebo-controlled clinical trial"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230644"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200309000-00003"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.06.019"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.10022"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00367.2005"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20060260"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80041-5"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80551-3"},{"key":"e_1_2_6_29_2","first-page":"914","volume-title":"Clinical Diagnosis and Management by Laboratory Methods","author":"Massey HD","year":"2001"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1997.d01-959.x"},{"key":"e_1_2_6_31_2","first-page":"991","article-title":"Interleukin\u20106 gene expression in human endothelial cells","volume":"159","author":"May LT","year":"1989","journal-title":"RNA starts sites, multiple IL-6 proteins and inhibition of proliferation"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01987902"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840040709"},{"key":"e_1_2_6_34_2","first-page":"85","article-title":"Endogenous cannabinoids","volume":"122","author":"Ros J","year":"2002","journal-title":"a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306062200"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707511"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3460835"},{"key":"e_1_2_6_38_2","first-page":"853","volume-title":"Molecular Biology of the Cell","author":"Alberts B","year":"2002"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50004"},{"key":"e_1_2_6_40_2","first-page":"669","volume-title":"Lipid\u2010Derived Autocoids","author":"Goodman LS","year":"2001"},{"key":"e_1_2_6_41_2","first-page":"145","volume-title":"Induction of COX\u20102 Expression by the Endocannabinoid Derivative R(+)\u2010Methanandamide","author":"Yazici Z","year":"2003"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01650-3"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206788200"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706928"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.12.050"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.131896"},{"key":"e_1_2_6_47_2","first-page":"671","article-title":"CB1 cannabinoid receptor antagonism","volume":"12","author":"Teixeira\u2010Clerc F","year":"2006","journal-title":"a new strategy for the treatment of liver fibrosis"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.01983.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2009.01983.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T18:50:56Z","timestamp":1697136656000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.01983.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,7]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1478-3231.2009.01983.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.01983.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,7]]}}}